大学糖尿病研究组进展报告。

Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):244-51.

The increase in cardiovascularortality associated with the use of oral hypoglycemic agents is emphasized. It is important that clinical pharmacologists take a more positive stand against the use of medications that have added risks that are not offset by actual benefits to the patient.

强调了使用口服降糖药与心血管死亡率增加之间的关联。临床药理学家必须对使用那些给患者带来额外风险且未被实际益处所抵消的药物采取更为积极的反对立场，这一点很重要。